Robert Burton Nussenblatt

Robert Burton Nussenblatt's AcademicInfluence.com Rankings

Philosophy

#3489

World Rank

#5629

Historical Rank

Logic

#1191

World Rank

#1875

Historical Rank

philosophy Degrees

Robert Burton Nussenblatt

Biology

#4377

World Rank

#6532

Historical Rank

Immunology

#182

World Rank

#190

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Robert Burton Nussenblatt's Degrees

Doctorate Medicine University of Pennsylvania
PhD Immunology University of Pennsylvania

Why Is Robert Burton Nussenblatt Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert Burton Nussenblatt's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. (2005) (3335)
Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. (1994) (937)
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. (2000) (892)
Standardizing immunophenotyping for the Human Immunology Project (2012) (752)
International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. (1987) (695)
TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 (2007) (640)
Uveitis: Fundamentals and Clinical Practice (1988) (606)
Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. (1985) (573)
The natural history of uveitis (1990) (460)
A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. (1988) (456)
Cutting Edge: NKT Cells Constitutively Express IL-23 Receptor and RORγt and Rapidly Produce IL-17 upon Receptor Ligation in an IL-6-Independent Fashion1 (2008) (430)
An unusually high prevalence of ocular toxoplasmosis in southern Brazil. (1992) (395)
Renal histopathologic alterations in patients treated with cyclosporine for uveitis. (1986) (325)
Chapter 3 Retinal specific antigens and immunopathogenic processes they provoke (1986) (309)
Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial. (1994) (304)
Intraocular lymphoma. Clinical and histopathologic diagnosis. (1993) (303)
Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. (1982) (297)
Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. (1983) (297)
Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. (1990) (284)
Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer. (2000) (281)
Side effects of systemic cyclosporine in patients not undergoing transplantation. (1984) (268)
Methotrexate for ocular inflammatory diseases. (2009) (267)
Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial. (1999) (266)
Epidemiology and course of disease in childhood uveitis. (2006) (246)
Macular thickening and visual acuity. Measurement in patients with cystoid macular edema. (1987) (238)
Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features. (1985) (231)
TREATMENT OF INTRAOCULAR INFLAMMATORY DISEASE WITH CYCLOSPORIN A (1983) (230)
Cyclosporine for ocular inflammatory diseases. (2010) (226)
Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium (2016) (218)
International Uveitis Study Group (IUSG) Clinical Classification of Uveitis (2008) (212)
Mycophenolate mofetil for ocular inflammation. (2010) (208)
Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity. (1999) (207)
Azathioprine for ocular inflammatory diseases. (2009) (205)
Pathology of experimental autoimmune uveoretinitis in mice. (1990) (202)
The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. (2002) (198)
Erratum: Standardizing immunophenotyping for the Human Immunology Project (2012) (196)
Effectiveness of cyclosporin therapy for Behçet's disease. (1985) (182)
Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. (1997) (181)
Cyclosporine: immunology, pharmacology and therapeutic uses. (1986) (175)
Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. (1995) (173)
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis. (1999) (168)
Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats. (1981) (167)
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study (2009) (162)
Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. (1988) (162)
Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis. (1991) (160)
A Pilot Study of CTLA-4 Blockade after Cancer Vaccine Failure in Patients with Advanced Malignancy (2007) (156)
ISOLATION OF HUMAN T-LYMPHOTROPIC VIRUS TYPE III FROM THE TEARS OF A PATIENT WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME (1985) (156)
S-antigen uveitis in primates. A new model for human disease. (1981) (156)
Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. (2012) (155)
Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial. (1997) (154)
A follow-up study of Toxoplasma gondii infection in southern Brazil. (2001) (152)
Complement component C5a Promotes Expression of IL-22 and IL-17 from Human T cells and its Implication in Age-related Macular Degeneration (2011) (150)
Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. (2013) (147)
Serpiginous choroiditis. (2005) (146)
Cyclophosphamide for ocular inflammatory diseases. (2009) (144)
Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. (1998) (142)
Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men. (1986) (135)
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity (2008) (132)
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. (2008) (126)
Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration. (2003) (124)
Age-related macular degeneration and the immune response: implications for therapy. (2007) (123)
32 cases of sympathetic ophthalmia. A retrospective study at the National Eye Institute, Bethesda, Md., from 1982 to 1992. (1995) (123)
Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications. (1991) (122)
Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine. (1986) (122)
Periocular corticosteroid injections in uveitis: effects and complications. (2014) (121)
Organ-resident, nonlymphoid cells suppress proliferation of autoimmune T-helper lymphocytes. (1987) (121)
Effects of Systemically Administered Hydrocortisone on the Human Immunome (2016) (121)
Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series. (2005) (121)
Immunocytochemical staining of vitreous cells. Indications, techniques, and results. (1992) (120)
IL-4 and IL-10 are both required for the induction of oral tolerance. (1999) (117)
HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia. (1990) (116)
Fundus autofluorescence imaging of the white dot syndromes. (2010) (115)
Glial retinal Müller cells produce IL-1 activity and have a dual effect on autoimmune T helper lymphocytes. Antigen presentation manifested after removal of suppressive activity. (1988) (115)
Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. (1994) (114)
Uveitis in Behçet's disease. (1997) (114)
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. (2008) (112)
Autoimmune retinopathy. (2014) (111)
Toxoplasma gondii: Acquired Ocular Toxoplasmosis in the Murine Model, Protective Role of TNF-α and IFN-γ (1994) (111)
Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) inhibit experimental autoimmune uveitis. (1993) (111)
Autoimmune and autoinflammatory mechanisms in uveitis (2014) (110)
Cutting Edge: In Vivo Blockade of Human IL-2 Receptor Induces Expansion of CD56bright Regulatory NK Cells in Patients with Active Uveitis (2005) (110)
Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease. (1994) (110)
Current practices in the management of ocular toxoplasmosis. (1991) (109)
Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema. (2001) (108)
Treatment of Cytomegalovirus Retinitis With Intraocular Sustained-Release Ganciclovir Implant-Reply (1995) (106)
Ocular immunopathology of Behçet's disease. (1997) (105)
Methods for Identifying Long-Term Adverse Effects of Treatment in Patients with Eye Diseases: The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study (2008) (102)
HLA-DR antigens on retinal pigment epithelial cells from patients with uveitis. (1986) (101)
Emerging drugs for uveitis (2011) (100)
Expression of cell adhesion molecules in posterior uveitis. (1992) (100)
A Double-masked, Randomized Study to Investigate the Safety and Efficacy of Daclizumab to Treat the Ocular Complications Related to Behçet's Disease (2007) (99)
Isolation of the human T-cell leukemia/lymphotropic virus type III from the cornea. (1986) (98)
Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma. (2009) (97)
Objective measurement of vitreous inflammation using optical coherence tomography. (2014) (96)
Diagnosis and management of primary intraocular lymphoma. (2005) (96)
Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis. (1997) (95)
Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia. (1985) (95)
Discrimination between patients with acquired toxoplasmosis and congenital toxoplasmosis on the basis of the immune response to parasite antigens. (2000) (95)
Allogenic fetal retinal pigment epithelial cell transplant in a patient with geographic atrophy. (1999) (93)
Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma. (2003) (91)
Ocular manifestations of central nervous system lymphoma (2001) (91)
Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome. (2004) (91)
An association between susceptibility to experimental autoimmune uveitis and choroidal mast cell numbers. (1984) (89)
Immunohistologic findings and results of treatment with cyclosporine in ligneous conjunctivitis. (1989) (89)
Modulation of experimental autoimmune uveitis with cyclosporin A. (1982) (87)
Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis (2010) (87)
Primary Intraocular Lymphoma: Diagnosis and Differential Diagnosis (2009) (85)
Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma. (2001) (85)
A standardized grading system for scleritis. (2011) (84)
T-lymphocyte subsets in experimental autoimmune uveitis. (1985) (81)
Frosted branch angiitis in a child with HIV infection. (2001) (81)
Risk of choroidal neovascularization among the uveitides. (2013) (80)
Clinical and Immunohistologic Studies of Corneal Rejection in the Rat Penetrating Keratoplasty Model (1991) (79)
Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents. (1998) (79)
A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis. (1996) (78)
Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier. (2003) (78)
Vitreous cytokine levels. (2003) (77)
Cyclosporine therapy for uveitis: long-term followup. (1985) (77)
A RANDOMIZED PILOT STUDY OF SYSTEMIC IMMUNOSUPPRESSION IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION WITH CHOROIDAL NEOVASCULARIZATION (2010) (77)
High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis. (2008) (76)
Monoclonal antibody against CD11b/CD18 inhibits endotoxin-induced uveitis. (1993) (76)
High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis. (2009) (75)
Experimental melanin-protein-induced uveitis in the Lewis rat. Immunopathologic processes. (1994) (74)
Progressive subretinal fibrosis and uveitis. (1984) (74)
Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat. (1987) (73)
Immunohistochemistry and electron microscopy of choroidal infiltrates and Dalen-Fuchs nodules in sympathetic ophthalmia. (1985) (73)
Immunopathologic study of Vogt-Koyanagi-Harada syndrome. (1988) (73)
Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens. (1989) (72)
Human T-cell leukemia/lymphotropic virus type III in the conjunctival epithelium of a patient with AIDS. (1985) (72)
Expression of Ia antigen on retinal pigment epithelium in experimental autoimmune uveoretinitis. (1986) (71)
Immunopathology of ocular onchocerciasis. 2. Anti-retinal autoantibodies in serum and ocular fluids. (1987) (70)
PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets (2010) (70)
Primary retinal vasculitis. Systemic associations and diagnostic evaluation. (1996) (70)
Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. (1995) (68)
High prevalence of unusual genotypes of Toxoplasma gondii infection in pork meat samples from Erechim, Southern Brazil. (2007) (68)
BENCH TO BEDSIDE: NEW APPROACHES TO THE IMMUNOTHERAPY OF UVEITIC DISEASE (2002) (68)
Effects of cyclosporine and other immunosuppressive drugs on experimental autoimmune uveoretinitis in rats. (1985) (68)
HTLV-III in the tears of AIDS patients. (1986) (68)
Iris involvement in primary intraocular lymphoma: report of two cases and review of the literature. (2000) (68)
Experimental autoimmune uveitis in the athymic nude rat (1982) (68)
Local cyclosporine therapy for experimental autoimmune uveitis in rats. (1985) (67)
Advances in the Management of AIDS-Related Cytomegalovirus Retinitis (1996) (67)
Inflammation in Retinal Disease (2013) (66)
Mycophenolate mofetil for the treatment of scleritis. (2003) (65)
Survival of donor epithelial cells after limbal stem cell transplantation. (2005) (65)
MCAM-expressing CD4(+) T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases. (2011) (65)
The role of chorioretinal biopsy in the management of posterior uveitis. (1993) (65)
Sympathetic ophthalmia. Immunopathological findings. (1986) (65)
Glucocorticoid-induced Tumor Necrosis Factor Receptor Negatively Regulates Activation of Human Primary Natural Killer (NK) Cells by Blocking Proliferative Signals and Increasing NK Cell Apoptosis* (2008) (64)
Human immunodeficiency virus disease: changing patterns of intraocular inflammation. (1998) (63)
Ocular Toxoplasmosis: An Old Disease Revisited (1994) (63)
Response of Pediatric Uveitis to Tumor Necrosis Factor-α Inhibitors (2013) (63)
Analysis of aqueous humor in ocular toxoplasmosis. (1991) (63)
Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis. (1995) (63)
Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia (2016) (62)
Hypopyon in patients with uveitis. (2010) (61)
Inflammatory Mechanisms of Age-related Macular Degeneration (2015) (61)
Inhibition of Inflammatory Cytokine Production in Human Corneal Cells by Dexamethasone, but Not Cyclosporin (2006) (60)
Identification of Toxoplasma gondii in paraffin-embedded sections by the polymerase chain reaction. (1990) (60)
Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A (2015) (60)
Clinical and immunopathological studies of pars planitis in a family. (1988) (59)
Experimental autoimmune uveitis and its relationship to clinical ocular inflammatory disease. (1996) (59)
Apoptosis in patients with posterior uveitis. (1997) (58)
Immune responses in age-related macular degeneration and a possible long-term therapeutic strategy for prevention. (2014) (58)
Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome (1999) (58)
Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy Using a Modified Delphi Approach. (2016) (58)
Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis. (2003) (57)
CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses (2015) (57)
Epidemiology of epiretinal membrane in a large cohort of patients with uveitis. (2014) (56)
Comparison of wide-field fluorescein angiography and 9-field montage angiography in uveitis. (2014) (56)
Gene Expression Profiling in Autoimmune Noninfectious Uveitis Disease1 (2008) (56)
Long-term culture of Muller cells from adult rats in the presence of activated lymphocytes/monocytes products. (1985) (55)
Therapy for human autoimmune uveitis with low-dose cyclosporine plus bromocriptine. (1988) (55)
Monoclonal antibodies against CD54 (ICAM-1) and CD11a (LFA-1) prevent and inhibit endotoxin-induced uveitis. (1995) (55)
FUNDUS AUTOFLUORESCENCE PATTERNS IN PRIMARY INTRAOCULAR LYMPHOMA (2011) (55)
Intraocular Inflammatory Disease (Uveitis) and the Use of Oral Tolerance. (1996) (55)
Modulation of Immune Responses by Extracellular Vesicles From Retinal Pigment Epithelium (2016) (54)
Ocular disease in patients with ANCA-positive vasculitis (2009) (54)
CD4+Foxp3+ T-regulatory cells in noninfectious uveitis. (2009) (53)
Histopathology of the subretinal fibrosis and uveitis syndrome. (1985) (53)
Dual effect of ciliary body cells on T lymphocyte proliferation (1990) (53)
Age-related macular degeneration: an immunologically driven disease. (2009) (52)
Extracellular HSP60 triggers tissue regeneration and wound healing by regulating inflammation and cell proliferation (2016) (52)
Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis (2015) (52)
Uveitis Scoring System (1991) (51)
The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis. (2015) (51)
Suppression of immune-mediated ocular inflammation in mice by interleukin 1 receptor antagonist administration. (2005) (50)
Infliximab for the treatment of active scleritis. (2009) (50)
Renal tubular function in cyclosporine-treated patients. (1986) (50)
Ophthalmic manifestations, cytology, immunohistochemistry, and molecular analysis of intraocular metastatic T-cell lymphoma: report of a case and review of the literature. (2008) (49)
Gamma interferon assay as an alternative to PPD skin testing in selected patients with granulomatous intraocular inflammatory disease. (2006) (49)
Retinal vascular endothelium expresses fibronectin and class II histocompatibility complex antigens in experimental autoimmune uveitis. (1987) (49)
Progressive outer retinal necrosis in the era of highly active antiretroviral therapy: successful management with intravitreal injections and monitoring with quantitative PCR. (2007) (49)
Involvement of the pineal gland in rats with experimental autoimmune uveitis. (1983) (49)
Therapeutic efficacy of intravitreal bevacizumab on posterior uveitis complicated by neovascularization (2009) (49)
Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma. (2006) (48)
Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema. (2014) (48)
Long-term daclizumab therapy for the treatment of noninfectious ocular inflammatory disease. (2011) (47)
Macular alterations secondary to intraocular inflammatory disease. (1986) (46)
Elevated Serum Levels of Interleukin-17A in Uveitis Patients (2013) (46)
A Case of Autoimmune Retinopathy Associated with Thyroid Carcinoma (2010) (46)
Improving the diagnostic yield of vitrectomy for intraocular lymphoma. (2000) (46)
Intraocular lymphoma (2002) (44)
Liver injury from cyclosporine A (1990) (44)
Effects of antiflammins on endotoxin-induced uveitis in rats. (1991) (44)
A clinicopathologic report of the retinal lesions associated with didanosine. (1994) (43)
Neoplastic masquerade syndromes in patients with uveitis. (2014) (43)
Immunohistochemistry findings in primary intraocular lymphoma. (1991) (43)
Adverse effects of smoking on patients with ocular inflammation (2010) (43)
Biologically active fibronectin fragments stimulate release of MCP-1 and catabolic cytokines from murine retinal pigment epithelium. (2009) (43)
Ectopic expression of gamma interferon in the eyes of transgenic mice induces ocular pathology and MHC class II gene expression. (1994) (43)
Adalimumab for Ocular Inflammation (2012) (42)
Uveitic foveal atrophy: clinical features and associations. (2009) (42)
Using interleukin 10 to interleukin 6 ratio to distinguish primary intraocular lymphoma and uveitis. (1999) (42)
The need for standardization of antiretinal antibody detection and measurement. (2008) (42)
Waldenström's macroglobulinemia-associated retinopathy. (2004) (41)
Splenectomy abrogates the induction of oral tolerance in experimental autoimmune uveoretinitis. (1993) (41)
Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS: The cytomegalovirus retreatment trial (1996) (41)
Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet). (1993) (41)
Cyclosporine penetration into the anterior chamber and cerebrospinal fluid. (1985) (41)
Ganciclovir implant exchange. Timing, surgical procedure, and complications. (1997) (41)
Behçet's disease: comparing 3 decades of treatment response at the National Eye Institute. (2008) (40)
Induction of oral tolerance to S-antigen induced experimental autoimmune uveitis by a uveitogenic 20mer peptide. (1991) (40)
International Central Nervous System and Ocular Lymphoma Workshop: Recommendations for the Future (2006) (40)
Pro-angiogenic effect of IFNγ is dependent on the PI3K/mTOR/translational pathway in human retinal pigmented epithelial cells (2009) (39)
Expression of GITR ligand abrogates immunosuppressive function of ocular tissue and differentially modulates inflammatory cytokines and chemokines (2006) (39)
Subconjunctival sirolimus in the treatment of diabetic macular edema (2011) (39)
Anti-la antibody diminishes ocular inflammation in experimental autoimmune uveitis (1988) (39)
Ocular toxoplasmosis: lessons from Brazil. (2015) (39)
Secretion of interleukin-17 by CD8+ T cells expressing CD146 (MCAM). (2014) (39)
Corneal endothelial deposits in children positive for human immunodeficiency virus receiving rifabutin prophylaxis for Mycobacterium avium complex bacteremia. (1999) (39)
Risk of hypotony in noninfectious uveitis. (2012) (39)
Granulomas in sympathetic ophthalmia and sarcoidosis. Immunohistochemical study. (1985) (39)
Syphilitic Outer Retinopathy (2014) (38)
Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-alpha and IFN-gamma. (1994) (38)
OCULAR TOXOPLASMOSIS IN THE FETUS: Immunohistochemistry Analysis and DNA Amplification (1994) (37)
Monoclonal antibodies to Müller's cells of the retina. (1984) (37)
Clinical studies of Vogt-Koyanagi-Harada's disease at the National Eye Institute, NIH, USA. (1988) (37)
Management of chronic pediatric uveitis (2005) (37)
Cyclosporin A: alterations of the cellular immune response in S-antigen-induced experimental autoimmune uveitis. (1983) (37)
Constitutive and cytokine-induced GITR ligand expression on human retinal pigment epithelium and photoreceptors. (2004) (36)
Endothelial leukocyte adhesion molecule-1 in endotoxin-induced uveitis. (1992) (36)
Characterization of a suppressor cell line which downgrades experimental autoimmune uveoretinitis in the rat. (1988) (36)
Subconjunctival sirolimus for the treatment of chronic active anterior uveitis: results of a pilot trial. (2012) (35)
gamma Interferon expression disrupts lens and retinal differentiation in transgenic mice. (1994) (35)
Ocular toxoplasmosis. An old disease revisited. (1994) (35)
Expression of Cell Adhesion Molecules in Corneal Graft Failure (1993) (35)
Histopathologic and immunohistopathologic features of subretinal fibrosis and uveitis syndrome. (1987) (35)
Murine model of primary intraocular lymphoma. (2005) (35)
Multicentric Kaposi's sarcoma of the conjunctiva in a male homosexual with the acquired immunodeficiency syndrome. (1983) (35)
From Cellular Characteristics to Disease Diagnosis: Uncovering Phenotypes with Supercells (2013) (34)
Chorioretinal, iris, and ciliary body infiltration by juvenile xanthogranuloma masquerading as uveitis. (1994) (34)
Identification of a uveitopathogenic and lymphocyte proliferation site in bovine S-antigen. (1988) (34)
T lymphocyte subsets in uveitis. (1983) (34)
Risk of Retinal Neovascularization in Cases of Uveitis. (2016) (33)
Primary testicular and intraocular lymphomas: two case reports and a review of the literature. (2006) (33)
Advances in the diagnosis and immunotherapy for ocular inflammatory disease (2008) (33)
Detection of molecular changes in primary intraocular lymphoma by microdissection and polymerase chain reaction. (1998) (32)
Down-regulation of autoantibody levels of cyclosporine and bromocriptine treatment in patients with uveitis. (1990) (32)
A masked, randomized, dose-response study between cyclosporine A and G in the treatment of sight-threatening uveitis of noninfectious origin. (1993) (32)
Optic neuritis and chronic relapsing experimental allergic encephalomyelitis: relationship to clinical course and comparison with multiple sclerosis. (1980) (32)
Visual prognosis and sympathetic ophthalmia. (1996) (32)
Clinical Use of Cyclosporine in Ocular Disease (1993) (31)
High-dose Intravenous Corticosteroids for Ocular Inflammatory Diseases (2012) (31)
Kinetics of T-lymphocyte subsets in the eyes of Lewis rats with experimental autoimmune uveitis. (1985) (31)
Risk of Ocular Hypertension in Adults with Noninfectious Uveitis. (2017) (30)
Unilateral cytomegalovirus retinochoroiditis and bilateral cytoid bodies in a bisexual man with the acquired immunodeficiency syndrome. (1983) (30)
Expression of class II antigen in endotoxin induced uveitis. (1986) (30)
Effects of topical FK506 on endotoxin-induced uveitis (EIU) in the Lewis rat. (1995) (30)
Uveitis-Associated Epitopes of Retinal Antigens Are Pathogenic in the Humanized Mouse Model of Uveitis and Identify Autoaggressive T Cells (2011) (30)
Proposed new classification scheme for chemical injury to the human eye. (2006) (30)
Immunologic mechanisms of uveitis. New targets for immunomodulation. (1997) (29)
Remission of Intermediate Uveitis: Incidence and Predictive Factors. (2016) (29)
LX211 (voclosporin) suppresses experimental uveitis and inhibits human T cells. (2009) (29)
The treatment of multifocal choroiditis associated choroidal neovascularization with sirolimus (rapamycin). (2007) (29)
25-Gauge transconjunctival sutureless vitrectomy for the diagnosis of intraocular lymphoma (2010) (28)
Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma. (2002) (28)
Elevation of laser flare photometry in patients with cytomegalovirus retinitis and AIDS. (1997) (28)
Risk of relapse in primary acute anterior uveitis. (2011) (28)
Presence of HTLV-III in tears and cells from the eyes of AIDS patients. (1987) (28)
Diagnosis of reactive lymphoid hyperplasia by chorioretinal biopsy. (1994) (28)
Intravitreal Methotrexate Resistance in a Patient with Primary Intraocular Lymphoma (2008) (28)
Inflammatory cellular kinetics in sympathetic ophthalmia a study of 29 traumatized (exciting) eyes. (1993) (28)
Dynamics of experimental autoimmune uveoretinitis induced by adoptive transfer of S-antigen-specific T cell line. (1988) (28)
Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor. (2016) (27)
Mammalian ciliary-body epithelial cells in culture produce transforming growth factor-beta (2004) (27)
Gevokizumab in the Treatment of Autoimmune Non-necrotizing Anterior Scleritis: Results of a Phase I/II Clinical Trial. (2016) (27)
Cytokine‐dependent Modulation of Oral Tolerance in a Murine Model of Autoimmune Uveitis (1996) (27)
Angiography with fluorescein-labeled dextrans in a primate model of uveitis. (1987) (27)
Endotoxin-induced uveitis in the rat: a hypothesis for preferential involvement of the anterior uvea. (1990) (27)
FK506 treatment of S-antigen induced uveitis in primates. (1991) (27)
Cyclosporine-induced nephrotoxicity in patients with autoimmune uveitis. (1985) (27)
Control of experimental autoimmune uveoretinitis by low dose T cell vaccination. (1992) (26)
PNEUMOCYSTIS CARINII AND MYCOBACTERIUM AVIUM‐INTRACELLULARE INFECTION OF THE CHOROID (1992) (26)
Antigen‐Driven Peripheral Immune Tolerance (1991) (26)
RETINAL S ANTIGEN REACTIVITY IN PATIENTS WITH RETINITIS PIGMENTOSA AND USHER'S SYNDROME (1984) (26)
FUNDUS AUTOFLUORESCENCE CHANGES IN CYTOMEGALOVIRUS RETINITIS (2010) (26)
Evolution of ciclosporin nephrotoxicity in patients treated for autoimmune uveitis. (1989) (26)
Translational Medicine - doing it backwards (2010) (26)
Primary intraocular lymphoma diagnosed by fine needle aspiration biopsy of a subretinal lesion. (2001) (26)
Sympathetic ophthalmia: what have we learned? (2009) (26)
Inflammatory cytokine and chemokine expression in sympathetic ophthalmia: a pilot study. (2011) (26)
The Immunological Basis of Degenerative Diseases of the Eye (2013) (25)
Antigen-driven peripheral immune tolerance. Suppression of organ-specific autoimmune diseases by oral administration of autoantigens. (1991) (25)
Endogenous bacterial retinitis in AIDS. (1989) (25)
Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with AIDS. (1991) (25)
Endotoxin-induced production of inflammatory mediators by cultured ciliary epithelial cells. (1990) (25)
Eradication of tumor colonization and invasion by a B cell-specific immunotoxin in a murine model for human primary intraocular lymphoma. (2006) (25)
Retrovirus-mediated gene transfer of ornithine-delta-aminotransferase into keratinocytes from gyrate atrophy patients. (1997) (24)
Diagnosis of ocular toxoplasmosis by the use of immunocytology and the polymerase chain reaction. (1994) (24)
The Effect of Long-term Intermittent Trimethoprim/Sulfamethoxazole Treatment on Recurrences of Toxoplasmic Retinochoroiditis: 10 Years of Follow-up (2015) (23)
Immunopathology of ocular onchocerciasis. I. Inflammatory cells infiltrating the anterior segment. (1989) (23)
Adenovirus-mediated gene transfer of ornithine aminotransferase in cultured human retinal pigment epithelium. (1996) (23)
Association of complement factor H tyrosine 402 histidine genotype with posterior involvement in sarcoid-related uveitis. (2013) (23)
Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis. (1995) (23)
Large cell lymphoma masquerading as a viral retinitis (1990) (23)
Kinetics of Corneal Transplant Rejection in the Rat Penetrating Keratoplasty Model (1994) (23)
Role of dendritic cell subsets in immunity and their contribution to noninfectious uveitis. (2015) (23)
Immunohistochemistry and electron microscopy of cyclitic membrane. Report of a case. (1986) (22)
Immunopathology of progressive subretinal fibrosis: a variant of sympathetic ophthalmia. (2004) (22)
Cyclosporine-induced specific unresponsiveness to retinal soluble antigen in experimental autoimmune uveoretinitis. (1988) (22)
Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases. (2012) (22)
Experimental autoimmune uveitis: cellular immune responsiveness. (1980) (22)
Unilateral pigmentary retinopathy associated with ocular toxoplasmosis. (1989) (21)
Optimal Use of Sandimmun in Endogenous Uveitis (1988) (21)
The role of macrophage class a scavenger receptors in a laser-induced murine choroidal neovascularization model. (2013) (21)
Subconjunctival Palomid 529 in the treatment of neovascular age-related macular degeneration (2013) (21)
Detection of human herpesvirus-8 and Epstein-Barr virus DNA in primary intraocular lymphomas. (1999) (21)
Differentiation of malignant B-lymphoma cells from normal and activated T-cell populations by their intrinsic autofluorescence. (2009) (21)
Antinuclear autoantibodies in uveitis. (1989) (21)
HTLV-1 infection of human retinal pigment epithelial cells and inhibition of viral infection by an antibody to ICAM-1. (2006) (20)
Diagnostic Procedures in Vitreoretinal Lymphoma (2014) (20)
Pharmacologic effects on the expression of class II histocompatibility antigen in experimental endotoxin-induced uveitis. (1987) (20)
Immunohistochemistry of the inflammatory response in Propionibacterium acnes endophthalmitis. (1991) (19)
Predominant usage of V beta 8.3 T cell receptor in a T cell line that induces experimental autoimmune uveoretinitis (EAU). (1992) (19)
Comparison between Methotrexate and Mycophenolate Mofetil monotherapy for the control of Non- Infectious Ocular Inflammatory Diseases. (2019) (19)
The role of mast cells in endotoxin-induced uveitis. (1993) (19)
Effects of cyclosporine on T-cell subsets in experimental autoimmune uveitis. (1985) (19)
Basic and clinical immunology in uveitis. (1987) (19)
Relentless placoid chorioretinitis associated with central nervous system lesions treated with mycophenolate mofetil. (2009) (19)
Iris inflammatory cells, fibronectin, fibrinogen, and immunoglobulin in various ocular diseases. (1988) (19)
Rituximab treatment for nonparaneoplastic autoimmune retinopathy. (2015) (19)
Antigen-directed retention of an autoimmune T-cell line. (1987) (19)
Cyclosporine A-induced arteriolopathy. (1988) (19)
Treatment of inflammatory macular edema with humanized anti-CD11a antibody therapy. (2011) (18)
Ophthalmologic Perspectives on Eye Irritation Testing (1998) (18)
Subconjunctival sirolimus in the treatment of autoimmune non-necrotizing anterior scleritis: results of a phase I/II clinical trial. (2015) (18)
Panax Notoginseng Saponin Controls IL-17 Expression in Helper T Cells. (2017) (18)
Association of antiretinal antibodies in acute annular outer retinopathy. (2008) (17)
Role of chorioretinal biopsy in inflammatory eye disease. (1991) (17)
Intraocular trafficking of lymphocytes in locally induced experimental autoimmune uveoretinitis (EAU). (1988) (17)
ELISA HIV Testing and Viral Culture in the Screening of Corneal Tissue for Transplant from Medical Examiner Cases (1989) (17)
Immunopathology of experimental autoimmune uveoretinitis in primates. (1992) (17)
Laser interferometry and visual prognosis in uveitis. (1985) (17)
Clinical Trials in Noninfectious Uveitis (2015) (16)
The small tellurium-based compound SAS suppresses inflammation in human retinal pigment epithelium (2016) (16)
Retinal lesions in children treated with dideoxyinosine. (1992) (16)
Association between mast cells and the development of experimental autoimmune uveitis in different rat strains. (1992) (16)
Presumed teratoma-associated paraneoplastic retinopathy. (2003) (16)
Immunopathology of ocular onchocerciasis 3. Th-2 helper T cells in the conjunctiva. (1993) (16)
Does anti-TNF therapy decrease the incidence of anterior uveitis in patients with ankylosing spondylitis? (2006) (16)
Immunosuppression in uveitis. (2002) (16)
Ciclosporin (Sandimmun) therapy: experience in the treatment of pars planitis and present therapeutic guidelines. (1992) (16)
Rabbit intraocular reactivity to endotoxin measured by slit-lamp biomicroscopy and laser flare photometry. (2012) (16)
Factors predictive of remission of new-onset anterior uveitis. (2014) (16)
Anti-Ia antibody diminishes ocular inflammation in experimental autoimmune uveitis. (1988) (16)
Iris lymphocytic infiltration in patients with clinically quiescent uveitis. (1987) (16)
Bilateral uveitis in a patient with autoimmune lymphoproliferative syndrome. (2005) (15)
ALTERED SUPPRESSOR-CELL ACTIVITIES IN UVEITIS (1980) (15)
The effect of cyclosporine on immunization with tetanus and keyhole limpet hemocyanin (KLH) in humans (1985) (15)
The Diagnosis of Intraocular Inflammation and Cytomegalovirus Retinitis in HIV-Infected Patients by Laser Flare Photometry Laser Flare Photometry in HIV-Infected Patients. (1996) (15)
Symmetric peripheral iris depigmentation in vogt-koyanagi-harada syndrome. (2002) (15)
Intravenous fluorescein interference with clinical laboratory tests. (1989) (15)
Treatment of Autoimmune Uveitis (1993) (15)
FR900506 (FK506) and 15-deoxyspergualin (15-DSG) modulate the kinetics of infiltrating cells in eyes with experimental autoimmune uveoretinitis. (1990) (15)
Vitamin E in the treatment of uveitis-associated macular edema. (2006) (15)
Role of Human Herpes Virus 6 in Corneal Inflammation Alone or With Human Herpesviruses (2011) (15)
Advances in Immunology: From Bench to Bedside—A Symposium at the 2005 Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS), Boston, MA, USA (2006) (14)
A comparison of the effectiveness of cyclosporine A, D, and G in the treatment of experimental autoimmune uveitis in rats. (1986) (14)
National Institutes of Health Center for Human Immunology Conference, September 2009 (2010) (14)
FLUORESCEIN ANGIOGRAPHY IN THE PROGRESSIVE OUTER RETINAL NECROSIS SYNDROME (1996) (14)
Remission Of Non-Infectious Anterior Scleritis: Incidence And Predictive Factors. (2019) (14)
Uveitis, the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT), and intravitreal biologics for ocular inflammation. (2012) (14)
Capnocytophaga canimorsus as the cause of a chronic corneal infection. (1990) (14)
Immune response to retinal antigens in patients with gyrate atrophy and other hereditary retinal dystrophies (2001) (14)
Improvement of uveitis and optic nerve disease by cyclosporine in a patient with multiple sclerosis. (1984) (14)
Uveitis in DiGeorge syndrome: a case of autoimmune ocular inflammation in a patient with deletion 22q11.2 (2010) (13)
Immunohistochemical markers in the normal human epibulbar conjunctiva from fetus to adult. (1988) (13)
Spontaneous lens subluxation in uveitis. (1990) (13)
SOCS5 mRNA levels in peripheral blood mononuclear cells (PBMC): a potential bio-marker for monitoring response of uveitis patients to Daclizumab therapy. (2005) (13)
Immunopathologic features of inflammatory coats disease. (2005) (13)
Comprar Uveitis, 4th Edition. Fundamentals and Clinical Practice: Expert Consult - Online and Print | Scott Whitcup | 9781437706673 | Mosby (2010) (13)
Scleritis and multiple systemic autoimmune manifestations in chronic natural killer cell lymphocytosis associated with elevated TCRα/β+CD3+CD4−CD8− double-negative T cells (2010) (13)
Subconjunctival corticosteroid injection for the treatment of non-necrotising anterior scleritis (2005) (13)
Presumed choroidal and orbital mastocytosis. (2001) (13)
Ocular manifestations of Behçet's disease. (1978) (13)
Diagnostic vitrectomy in intermediate uveitis. (1992) (13)
T cell receptor β-chain usage in experimental autoimmune uveoretinitis (1991) (13)
The scoring system (1991) (13)
Iridocyclitis in black Americans: association with HLA B8 suggests an autoimmune aetiology. (1981) (13)
Retrovirus-mediated gene transfer and expression of human ornithine delta-aminotransferase into embryonic fibroblasts. (1994) (13)
Treating intraocular inflammatory disease in the 21st century. (2005) (13)
Inhibition of T lymphocyte proliferation by retinal glial Müller cells: reversal of inhibition by glucocorticoids. (1991) (13)
Immunospecific suppression of encephalitogenic-activated T lymphocytes by chimeric cytotoxin IL-2-PE40. (1991) (13)
Recalcitrant Granulomatous Sclerouveitis in a Patient with Granulomatous ANCA-associated Vasculitis (2009) (12)
Lymphocyte migration in the adoptive transfer of EAU. (1986) (12)
The expanding use of immunosuppression in the treatment of non-infectious ocular disease. (1992) (12)
Immunology of intermediate uveitis. (1992) (12)
Enhanced Depth Imaging Optical Coherence Tomography in Uveitis: An Intravisit and Interobserver Reproducibility Study. (2016) (12)
Cyclosporine-induced alterations of humoral response in experimental autoimmune uveitis. (1984) (12)
The tellurium redox immunomodulating compound AS101 inhibits IL-1β-activated inflammation in the human retinal pigment epithelium (2013) (12)
Surgical approaches to uveitis. (1990) (11)
Corticosteroid-associated Osteonecrosis: A Rare, but Serious, Complication in Uveitis (2013) (11)
Exudative Retinal Detachment in Ocular Inflammatory Diseases: Risk and Predictive Factors. (2020) (11)
Cellular immune responses to retinal antigens in retinitis pigmentosa (2004) (11)
Cyclosporine and dexamethasone inhibit T-lymphocyte MHC class II antigens and IL-2 receptor expression in experimental autoimmune uveitis. (1987) (11)
Quality of Life in Sarcoidosis: Comparing the Impact of Ocular and Non-ocular Involvement of the Disease (2010) (11)
DELINEATION OF CHOROIDAL AND RETINAL LESIONS IN POSTERIOR UVEITIS BY MULTISPECTRAL WIDE-FIELD SCANNING LASER OPHTHALMOSCOPY (2016) (11)
Progression of varicella-zoster virus necrotizing retinopathy in an HIV-negative patient with transient immune deviation (2005) (11)
C5a contributes to intraocular inflammation by affecting retinal pigment epithelial cells and immune cells (2011) (11)
Injury of Müller cells increases the incidence of experimental autoimmune uveoretinitis. (1991) (11)
Treatment of Intraocular Complications of Sarcoidosis (1986) (11)
Polymerase chain reaction-based ganciclovir resistance testing of ocular fluids for cytomegalovirus retinitis. (2012) (11)
Overexpression of IL-17RC associated with ocular sarcoidosis (2014) (11)
Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium (2016) (11)
7 – Philosophy, Goals, and Approaches to Medical Therapy (2010) (10)
The effect of bromocriptine on anterior uveitis. (1988) (10)
Developmental expression of S-antigen in fetal human and rat eye. (1992) (10)
29 – White-Dot Syndromes (2010) (10)
Perspectives on gene therapy in the treatment of ocular inflammation (1997) (10)
Chronic uveitis in guinea pigs infected with varicella-zoster virus expressing Escherichia coli beta-galactosidase. (1998) (10)
Assessment of visual function in patients with gyrate atrophy who are considered candidates for gene replacement. (2001) (10)
HLA in intermediate uveitis. (1992) (10)
Fluocinolone acetonide for the treatment of uveitis: weighing the balance between local and systemic immunosuppression. (2008) (10)
A rare case of endogenous Aspergillus conicus endophthalmitis in an immunocompromised patient (2013) (10)
Long-term antigen specific and non-specific T-cell lines and clones in uveitis. (1984) (10)
Fundus Autofluorescence and OCT in the Management of Progressive Outer Retinal Necrosis. (2010) (10)
Cryopexy enhances experimental autoimmune uveoretinitis (EAU) in rats. (1989) (10)
Immunohistochemical staining of sebaceous cell carcinoma of the eyelid. (1989) (10)
Levels of blood CD1c+ mDC1 and CD1chi mDC1 subpopulation reflect disease activity in noninfectious uveitis. (2014) (10)
Analysis of autoantibodies among patients with primary and secondary uveitis: high incidence in patients with sarcoidosis. (1992) (10)
Recombinant adenovirus encoding gp100 modulates experimental melanin-protein induced uveitis (EMIU). (1998) (9)
Cytomegalovirus retinitis successfully treated with ganciclovir implant in a patient with blood ganciclovir resistance and ocular ganciclovir sensitivity (2012) (9)
Review: implants. (1994) (9)
Orally and Nasally Induced Tolerance Studies in Ocular Inflammatory Disease: Guidance for Future Interventions (2004) (9)
Comparative efficacy of steroid-sparing therapies for non-infectious uveitis (2017) (9)
Increased CD1c+ mDC1 with mature phenotype regulated by TNFα-p38 MAPK in autoimmune ocular inflammatory disease. (2015) (9)
Interleukin-2 Receptor Targeted Therapy of Ocular Disease of HTLV-1-associated Adult T-cell Leukemia (2012) (9)
Heterologous epitopes of IRBP protect against autoimmune uveitis induced by the autologous epitope (1998) (8)
Primary diffuse large B‐cell lymphoma of the spleen with coincident serous retinal detachments responsive to corticosteroids (2007) (8)
Immunohistochemical localization of T lymphocytes and macrophages and expression of interferon gamma and defensin in uveitis. (1994) (8)
B Cell Anomalies in Autoimmune Retinopathy (AIR) (2017) (8)
[Immunologic suppression of experimental autoimmune uveitis]. (1991) (8)
Pharmacogenetics of drugs used in the treatment of ocular inflammatory diseases (2013) (8)
Introduction to Uveitis (2008) (8)
Enhancing effect of cyclosporins A and G on bone marrow colony formation. (1990) (8)
Visual Acuity Outcome over Time in Non-Infectious Uveitis (2019) (8)
Autoimmune Retinopathy: Prognosis and Treatment (2010) (8)
Blood–Retinal Barrier, Immune Privilege, and Autoimmunity (2012) (8)
Protean manifestations of pediatric neurosarcoidosis. (2009) (8)
Antiphospholipid Antibody Syndrome Mimicking Serpiginous Choroidopathy (2009) (8)
Immunohistopathology of experimental uveitis induced by a non-ocular antigen. (1986) (7)
Occult primary carcinoma metastatic to the iris. (2004) (7)
Phakic patients with cystoid macular edema, retinal periphlebitis, and vitreous inflammation. (1998) (7)
Treatment of Cytomegalovirus Retinitis with an Intraocular Sustained-Release Ganciclovir Implant: A Randomized Controlled Trial (1995) (7)
HYDERGINE AND CYCLOSPORIN NEPHROTOXICITY (1986) (7)
Chorioretinal biopsy for diagnostic purposes in cases of intraocular inflammatory disease. (1992) (7)
The Use of Mycophenolate Mofetil for the Treatment of Non-Infectious Uveitis in Children (2002) (7)
Elevated CD1c+ Myeloid Dendritic Cell Proportions Associate With Clinical Activity and Predict Disease Reactivation in Noninfectious Uveitis (2016) (7)
Immune response to intraocular injection of retinal S-antigen in adjuvant (2005) (7)
Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated With Juvenile Idiopathic Arthritis: The SITE Study (2012) (7)
Factors Predictive of Remission of Chronic Anterior Uveitis. (2019) (7)
Treatment of experimental autoimmune uveitis in the rat with systemic succinylacetone. (1988) (7)
The Chinese medicine formula HB01 reduces choroidal neovascularization by regulating the expression of vascular endothelial growth factor (2012) (7)
Orbital Lymphoma Masquerading as Panuveitis (2010) (6)
Medical process : ophthalmology (1990) (6)
The use of the flarephotometry in the detection of cytomegalic virus retinitis in AIDS patients. (1994) (6)
1 – *Elements of the Immune System and Concepts of Intraocular Inflammatory Disease Pathogenesis (2010) (6)
The status of clinical trials: Cause for concern (2010) (6)
Experimental autoimmunity. (1986) (6)
WALDENSTRÖM'S MACROGLOBULINEMIA MASQUERADING AS BIRDSHOT CHORIORETINOPATHY (2017) (6)
The use of cyclosporine in ocular inflammatory disorders. (1988) (6)
Corrigendum: Effects of Systemically Administered Hydrocortisone on the Human Immunome (2016) (5)
Susceptibility Genes and Pharmacogenetics in Ocular Inflammatory Disorders (2012) (5)
Corticosteroids enhance S-antigen expression in nonretinal ocular tissues of rats with experimental autoimmune uveitis. (1994) (5)
Gradient Boosted Decision Tree Classification of Endophthalmitis Versus Uveitis and Lymphoma from Aqueous and Vitreous IL-6 and IL-10 Levels. (2017) (5)
Biologic Therapies: Anti-Tumor Necrosis Factor-α, Anti-Interleukins, Rituximab and Others. (2016) (5)
FK 506 treatment of experimental autoimmune uveoretinitis in primates. (1991) (5)
Subretinal fibrosis in Vogt-Koyanagi Harada syndrome. (2001) (5)
Ocular fluorescein clearance in patients with hypotony secondary to chronic uveitis. (1988) (5)
This information is current as Active Uveitis Regulatory NK Cells in Patients withbright IL-2 Receptor Induces Expansion of CD 56 Cutting Edge : In Vivo Blockade of Human (2005) (5)
Posterior Uveitis: Diagnosis and Management (1994) (5)
FAILURE OF ARGON LASER TO HALT CYTOMEGALOVIRUS RETINITIS (1986) (5)
Intraocular Ia expression in vivo induced in the absence of immune T cells. (1987) (5)
Immunoregulation of uveitis (2004) (4)
23 – Sympathetic Ophthalmia (2010) (4)
Pharmacologic Treatment of Noninfectious Uveitis. (2016) (4)
Chapter 79 – Immunologic mechanisms of uveitis (2010) (4)
Reduction of cyclosporine dosage with ketoconazole in a patient with birdshot retinochoroidopathy. (1998) (4)
Retinal Pigment Epithelium Tear after Immunosuppressive Treatment for Sarcoidosis-related Choroidal Granuloma (2017) (4)
Telomere Length of peripheral leukocytes is shortened in Ocular Sarcoidosis patients (2013) (4)
This research is supported by intramural funding from the Na- tional Eye Institute, National Institutes of Health. Steven Yeh has received support from the Heed Ophthalmic Foundation. (2009) (4)
8 – Role of Surgery in the Patient with Uveitis (2010) (4)
Therapeutic options for the treatment of non-infectious uveitis (2015) (4)
Emerging biologics in the treatment of uveitis (2007) (4)
24 – Vogt–Koyanagi–Harada Syndrome (2010) (4)
Chapter 77 – Autoimmune Retinopathies (2013) (4)
Human immunodeficiency virus, herpes zoster, and the retina. (1991) (4)
Genetic and Epigenetic Regulation in Age-Related Macular Degeneration (2013) (4)
Risk of Cataract in Intermediate Uveitis. (2021) (4)
Gene therapy in the treatment of ocular inflammation (2004) (4)
Gamma-interferon induces differential expression of HLA-DR, -DP and -DQ in human ciliary epithelial cells (1991) (4)
The induction of tolerance by cyclosporine-G in experimental autoimmune uveitis in the Lewis rat. (1987) (4)
Use of microdissection and molecular genetics in the pathologic diagnosis of retinoblastoma. (1999) (3)
Levels of IL-10 and IL-6 in the Vitreous are Helpful for Differential Diagnosis of Primary Intraocular Lymphoma and Ocular Inflammation (2002) (3)
Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56bright regulatory NK cells in patients with active uveitis (2005) (3)
17 – Onchocerciasis and Other Parasitic Diseases (2010) (3)
Specific clinical entities (1991) (3)
The National Institutes of Health Center for Human Immunology, Autoimmunity, and Inflammation: history and progress (2013) (3)
The Use of Microsatellite Analysis to Determine the Survival of Donor Epithelial Cells After Limbal Stem Cell Transplantation (2002) (3)
Incidence and Risk Factors for Ocular Hypertension in Adults with Non-infectious Uveitis (2014) (3)
Epidemiologic Methods for Detecting Rare, Long-Term Adverse Events Associated With Eye Diseases: The Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study (2007) (3)
Cataracts and Allergic Encephalomyelitis (1981) (3)
26 – Behçet's Disease (2010) (3)
Vogt-Koyanagi-Harada Syndrome (1976) (3)
Age-related macular degeneration in patients with uveitis (2016) (3)
Suppression of S-antigen-induced experimental autoimmune uveoretinitis in Lewis rats by oral administration with CGS-13080, a thromboxane synthetase inhibitor. (1993) (3)
TREATMENT OF RETINAL VASCULITIS (1998) (3)
GITR Negatively Regulates Activation of Primary Human NK Cells by Blocking Proliferative Signals and Increasing NK Cell Apoptosis (2008) (3)
IL-17A and IL-17RC Expression in the Macula of the Human Eye with Age-Related Macular Degeneration (2012) (3)
Proposed Immune Mechanisms in Uveitis and Their Modulation (1985) (3)
Ocular Inflammatory Disorders in Autoimmune Lymphoproliferative Syndrome (ALPS) (2017) (3)
Chronic eyelid closure and its effect upon the human cone and rod electroretinogram. (1987) (3)
The clinical use of immunosuppressants in the treatment of putative autoimmune intra-ocular diseases (1988) (3)
High Frequency of Circulating CD8+ Memory Stem T Cells in Acquired Aplastic Anemia (2015) (3)
Induction of MHC class II antigen in cultured bovine ciliary epithelial cells (2004) (3)
Infections Associated with Retinal Autoimmunity (2015) (2)
OX40 ligand expression abrogates the immunosuppressive function of retinal pigment epithelium (2013) (2)
Optical Coherence Tomography, Fundus Autofluorescence, and Fluorescein Angiography in Non-Paraneoplastic Autoimmune Retinopathy (2013) (2)
Strategies for the treatment of intraocular inflammatory disease. (1998) (2)
Corneal Endothelial Transplantation in Uveitis: Incidence and Risk Factors. (2021) (2)
Ocular complications of the acquired immunodeficiency syndrome. (1988) (2)
Risk of Elevated Intraocular Pressure (IOP) in Pediatric Non-infectious Uveitis (2014) (2)
Neoplastic Masquerade Syndromes among Uveitis Patients (2014) (2)
Ocular Inflammation and Neovascularization (2006) (2)
Intravenous Pulsed Corticosteroids for Ocular Inflammatory Diseases (2010) (2)
Uveitis in 2008: a festschrift for G. Richard O'Connor, MD. (2008) (2)
Immunopharmacological studies of qingkaining, a Chinese blended medicine: effects on experimental autoimmune uveoretinitis in the rat. (1989) (2)
Ocular inflammation stimulated by the immunomodulator AS101 [ammonium trichloro(dioxyethelene-O-O') tellurate]. (1994) (2)
Junctional changes in retinal vessels of a monkey with IRBP-induced retinouveitis (1987) (2)
Enhancement of S-antigen and its mRNA in the irides of uveitic patients. (1992) (2)
Introduction: Endogenous Uveitis (1988) (2)
Immunosuppresive Therapy in Ocular Surface Transplantation (2002) (2)
Application of small molecules/macromolecules in ocular inflammatory diseases. (2012) (2)
Rules to Prevent Conflict of Interest for Clinical Investigators Conducting Human Subjects Research (2007) (2)
Methotrexate vs. Mycophenolate Mofetil for Ocular Inflammatory Diseases (2012) (2)
Pathogenesis of uveitis. (1988) (2)
[Active immune regulation by cells of the ciliary body]. (1991) (2)
Human monocyte subsets differentially drive T helper cell polarization: implications for the pathogenesis and treatment of autoimmune uveitis (2013) (1)
Integrity in Research: Principles for the Conduct of Research (2018) (1)
Multiple Evanescent White Dot Syndrome (MEWDS) (2016) (1)
Chemokine and Chemokine Receptor Expression in Two Models of Primary Intraocular Lymphoma (2006) (1)
Combination Daclizumab/Sirolimus Therapy for the Induction of Immune Tolerance in Non-Infectious Intermediate and Posterior Uveitis (2009) (1)
Gene Expression Profiling of Non-Infectious Uveitis Patients Using Pathway Specific cDNA Microarray Analysis (2007) (1)
Retinal injury enhances the development of experimental autoimmune uveoretinitis (1987) (1)
Daclizumab and Its Effect on Chronic Uveitic CME (2009) (1)
The Effects of Pigment Epithelial Derived Factor on Murine Macrophages (2009) (1)
Suggested Treatment Schedule with Sandimmun (1988) (1)
[Differential expression of HLA DR, DP and DQ in cultivated, human ciliary body epithelial cells]. (1991) (1)
14 – Ocular Toxoplasmosis (2010) (1)
28 – Serpiginous Choroidopathy (2010) (1)
A Case of Rapid Progression and Vision Loss in a Patient with Primary Intraocular Lymphoma (2010) (1)
Increased Survival of a Cohort of Patients with Acquired Immune Deficiency Syndrome and Cytomegalovirus Retinitis Who Received Sodium Phosphonoformate (1993) (1)
Fundus autofluorescence and optical coherence tomography in the management of progressive outer retinal necrosis (2013) (1)
Ocular disease phenotyping from multiparameter cell analysis by machine learning algorithms (2016) (1)
Dermatologic Adverse Events With Daclizumab Therapy for Non-Infectious Uveitis (2008) (1)
Treatment with TNF inhibitors for uveitis associated with juvenile idiopathic arthritis (2007) (1)
Clinical Allergy and Immunology of the Eye (1983) (1)
The Weight of the Basic and Clinical Science Course (2003) (1)
Optical Coherence Tomography for the Assessment of Cystoid Macular Edema in Patients with Uveitis (2004) (1)
Risk Factors For Retinal Neovascularization In Patients With Uveitis (2011) (1)
15 – Ocular Histoplasmosis (2010) (1)
Double Negative T Cells in Uveitis (2010) (1)
CHAPTER 14 – Ocular Diseases of Presumed Autoimmune Origin (1985) (1)
Effectiveness of Ciclosporin on Sight-threatening Endogenous Uveitis (1985) (1)
Clinical pathologic findings of Propionibacterium acnes endophthalmitis. (1996) (1)
Renal Tubular Function in Cyclosporine-Treated Patients (1987) (1)
Biologic therapiesinfliximab, adalimumab, etanercept, daclizumab, and others (2010) (1)
Is anti-tumor necrosis factor therapy effective in reducing uveitis flares in patients with spondyloarthropathies? (2007) (1)
Contemporaneous Risk Factors for Visual Acuity in Non-Infectious Uveitis. (2021) (1)
Overexpression of IL-17RC associated with ocular sarcoidosis (2014) (1)
Intravitreal Injection of Interleukin 1 Receptor Antagonist Suppresses Experimental Autoimmune Uveoretinitis in Lewis Rats (2005) (1)
T cell receptor beta-chain usage in experimental autoimmune uveoretinitis. (1991) (1)
Corrigendum to “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration” [J. Autoimmun. 21 (2004) 283–293] (2004) (1)
Reducing variability in flow cytometry (2012) (1)
The Prevalence, Incidence and Risk Factors for Exudative Retinal Detachment in Uveitis (2013) (0)
The Chinese medicine formula HB01 reduces choroidal neovascularization by regulating the expression of vascular endothelial growth factor (2012) (0)
Behcet Disease in the United States: Ocular and Systemic Manifestations (2014) (0)
Ultrastructural changes of retinal vascular endothelial cells at the onset of experimental autoimmune uveitis (1992) (0)
Dendritic cells from uveitis patients have a mature phenotype and a reduced capacity to take up antigen (2013) (0)
Correlation Between Spectral Domain Optical Coherence Tomography And Fluorescein Angiography With Visual Acuity In Patients With Uveitic Macular Edema (2011) (0)
P161 CD14CD16 MONOCYTES FROM PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS DRIVE MEMORY T CELL PROLIFERATION AND POLARISE THEM TO A STEROID RESISTANT TH17 PHENOTYPE (2014) (0)
Differential Activation and Apoptotic Response of Human Lymphocytes to TCR Stimulation Among Non–Infectious Uveitis Patients and Normal Donors (2006) (0)
Clinical Features of Autoimmune Retinopathy Associated With Anti-Retinal Antibodies (2007) (0)
Targeted B-cell Therapy with Rituximab for the Treatment of Autoimmune Retinopathy: Results of a Pilot Clinical Trial (2013) (0)
A proposed classification scheme for chemical injury to the human eye (1999) (0)
Association of Propionibacterium acnes endophthalmitis with HLA-DQw5 (1997) (0)
Methods of treating autoimmune uveoretnitis in humans (1990) (0)
The Role of the bcl–2 t(14;18) Translocation in Clinical Outcomes of Primary Intraocular Lymphoma (2005) (0)
Clinical Utility of Polymerase Chain Reaction of Ocular Fluid in Uveitis Patients (2012) (0)
This information is current as Anemia Memory Stem Cells in Acquired Aplastic + Disease : High Frequency of Circulating CD 8 Memory Stem T Cells in Autoimmune (2016) (0)
Autoimmune Ocular Disorders (1997) (0)
Adamantiades–Behcet's Disease: A Trend in Time (2005) (0)
Modulation of monocyte activation by retinal pigment epithelium (RPE)-derived exosomes (2015) (0)
Th1 Cells Express IFN-Gamma, and M1 Macrophages CCL19/CXCL11 and IL-17/IL-18/IL-23 in Sympathetic Ophthalmia (2009) (0)
The Role of Humanized Anti–IL–2 Receptor Antibody (HAT) Therapy in Incontrolled Uveitis (2004) (0)
Immunotherapy of Uveitis (2019) (0)
Altered CD8+ T cell function in human non-infectious uveitis (2013) (0)
Daclizumab for Active, Non-Infectious, Sight-Threatening Uveitis: A Phase II Pilot Study (2008) (0)
Single Cell Cytokine Profiling of Non-Infectious Uveitis Patients and Normal Controls Using a Multi-Color Intracellular Staining Strategy (2008) (0)
Intravitreal Triamcinolone Acetonide in the Treatment of Serous Retinal Detachment in Vogt–Koyanagi–Harada Syndrome (2004) (0)
Treatment of Active Anterior Uveitis Associated With JIA Using Daclizumab (2009) (0)
270 FK-506 inhibits IgE receptor mediated exocytosis from rat basophilic leukemia cells without affecting pi hydrolysis or calcium uptake (1991) (0)
Patient Selection for Sandimmun Treatment (1988) (0)
Complement Fragment C5a Activates Retinal Pigment Epithelial Cells and Contributes to the Pathogenesis of Age-Related Macular Degeneration (2010) (0)
Multi-view Optical Coherence Tomography (2018) (0)
The Elevation Of Cd14high16+ Monocytes In Uveitis Patients (2012) (0)
CHAPTER 24 – Writing a Protocol (2007) (0)
Aqueous Levels of Interleukin-6 in Patients with Uveitis (2011) (0)
Commentarystatus of clinical trials: Cause for concern (2010) (0)
Noninfectious Uveitis Disease Gene Expression Profiling in Autoimmune (2008) (0)
Infliximab for the Treatment of Scleritis and Chronic Recalcitrant Uveitis (2008) (0)
16 – Toxocara canis (2010) (0)
Chapter 32 – Writing a Protocol (2012) (0)
Corticosteroid resistant Th17 cells are sensitive to calcineurin inhibition (2014) (0)
Unilateral cytomegalovirus retinochoroiditis and bilateral cytoid bodies in a bisexual man with the acquired immunodeficiency syndrome. (1984) (0)
Cloning and Expression of Glucocorticoid–Induced TNF Receptor–Related Ligand (GITRL) in Human Retinal Pigment Epithelial Cells (2005) (0)
General approach to scoring (1991) (0)
Pathway Specific Gene Expression Profiling in a Laser-induced Choroidal Neovascularization (cnv) Mouse Model (2009) (0)
Indocyanine Green Angiography and Scanning Laser Ophthalmoscope Microperimetry in Punctate Inner Choroidopathy: Case Report (2009) (0)
Types of uveitis (1991) (0)
Inflammatory Response and Involvement of Immune Components in a Laser Induced CNV (Choroidal Neovascularization) Mouse Model (2008) (0)
Authors' response (2011) (0)
Efficacy Of Mycophenolate Mofetil In Treatment Of Ocular Inflammatory Disease (2002) (0)
Works Title Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy Using a Modified Delphi Approach Permalink (2016) (0)
Serum Leptin Levels in Autoimmune Uveitis (2006) (0)
25 – Birdshot Retinochoroidopathy (2010) (0)
Application of Antigen Retrieval and Immunohistochemistry to Study the Expression of GITRL in Normal and Diseased Ocular Tissue (2005) (0)
Advances in ocular immunology : proceedings of the 6th International Symposium on the Immunology and Immunopathology of the Eye, Bethesda, USA (1994) (0)
Primary Intraocular Lymphoma–A Descriptive Analysis of 2 Decades of Experience at the NEI (2006) (0)
Autofluorescence Can be Used to Differentiate Between Normal, Activated, or Malignant Lymphocyte Populations (2007) (0)
OX40 Ligand (OX40L) and Its Potential Role in Ocular Inflammation: An in vitro Approach (2008) (0)
Factors That Influence Long Term Survival in Patients with Primary Intraocular Lymphoma (2003) (0)
Thil17 Plays a Role in Uveitis and Its Expansion Is Inhibited by Il-27 (2007) (0)
Human Monocytes Heterogeneity And Its Implication In Uveitis Therapy (2011) (0)
Glucocorticoid Increases Cd14HighCd16+ Monocyte Population And Contributes To Uveitis Therapy (2012) (0)
Ocular Complications of Sarcoidosis (2006) (0)
Role of the Macrophage Scavenger Receptor in the Laser-Induced Experimental Choroidal Neovascularization (CNV) Mouse Model (2010) (0)
Present Experience with Sandimmun (1988) (0)
Age-Related Macular Degeneration among Uveitis Patients (2014) (0)
Myeloid dendritic cells with elevated CD1c expression in non-infectious uveitis patients exhibited mature phenotype through the regulation of TNFa-p38 MAPK pathway (HUM1P.273) (2015) (0)
Failure in Patients with Advanced Malignancy A Pilot Study of CTLA-4 Blockade after Cancer Vaccine (2007) (0)
Incidence and Risk factors for Hypotony in Uveitis (2011) (0)
Immuno-Modulatory Effect of Human Fetal Retinal Pigment Epithelial (fRPE) Cells on Monocyte Differentiation and Maturation (2009) (0)
Inflammatory Markers in the Baseline Evaluation of Uveitis Patients (2011) (0)
Development of an Imaging Approach for Inflammatory and Neoplastic Ocular Lesions by Establishing Specific Identification of T-cells In Vitro with Indocyanine Green Fluorescence (2014) (0)
Risk Of Clinically Manifest Hyperglycemia Among Patients Receiving Systemic Corticosteroids For Inflammatory Eye Disease (2011) (0)
Cyclosporin a alters clinical and immune features in experimental autoimmune uveitis (1982) (0)
Toxoplasma gondii infection in pork meat samples from Erexim. Phase I: Characterization of the rate of contamination and identification of the organisms from tongue and diaphragm. (2004) (0)
Chapter 55 – Ocular Disease (2014) (0)
Clinical Outcomes of Patients With Behcet’s Disease Associated Ocular Inflammation (2008) (0)
Retinal Autoimmunity (2006) (0)
Can Bone Marrow Stem Cells Trans-differntiate into Ocular Surface Epithelial Cells? (2003) (0)
The Role of Macrophage Class A Scavenger Receptors on CNV Formation in a Laser-induced Murine CNV Model (2011) (0)
GITR Ligand Is Expressed in the Eye and Inhibits CD4+ T Cell Proliferation (2003) (0)
Remission Of Intermediate Uveitis: Rate And Predictive Factors (2012) (0)
Immune Marker Changes in Patients with Non-Paraneoplastic Autoimmune Retinopathy (2013) (0)
Enhanced Depth Imaging Optical Coherence Tomography (EDI-OCT) in Uveitis: An Intra-Session and Inter-Observer Reproducibility Study (2015) (0)
Alpha Tropomyosin as a self antigen in Behcet's disease (2004) (0)
Side Effects of Systemic Cyclosporine in Patients Not Undergoing Transplantation (1985) (0)
Acute Posterior Multifocal Placoid Pigment Epitheliopathy (2016) (0)
Immunology, keeping pace with change (2005) (0)
27 – Retinal Vasculitis (2010) (0)
Intravitreal Injection of Anti-interleukin-2 Receptor in Experimental Autoimmune Uveoretinitis (EAU) (2003) (0)
Pujari et al Cyclophosphamide for Ocular Inflammation (0)
Mycophenolate Mofetil in Non-Infectious Ocular Inflammatory Diseases (2009) (0)
Uveitis: A Colour Manual of Diagnosis and Treatment (1988) (0)
Posterior Uveitis and Retinitis (1985) (0)
Erratum: Diagnostic and therapeutic challenges (Retina (2010) 30 (700-704)) (2010) (0)
Detection of bcl–2/IgH Gene Translocations in Primary Intraocular Lymphoma (2004) (0)
Contents, Vol. 70, 1983 (1983) (0)
General guidelines for immunosuppresive therapy with steroids and cytotoxic agents in uveitis (1981) (0)
Dissociated immune responses to lens antigens 33 Table I . Immune responses to various tissue extracts of a rabbit immunized against rat lens (2005) (0)
Pathophysiology of uveitis and therapeutic intervention. (1985) (0)
Evaluation of Patients with a White Dot Syndrome (2016) (0)
Su.127. Eradication of Tumor Colonization and Invasion By a B-Cell Specific Immunotoxin in a Murine Model for Human Primary Intraocular Lymphoma (Piol) (2006) (0)
Clinical gene therapy trial for gyrate atrophy (1998) (0)
Chapter 77 – Retinal Autoantibodies (2014) (0)
The Role of Ultrasound Biomicroscopy in Assessment of Patients with Anterior Segment Ocular Inflammatory Disease (2003) (0)
LX211 (ISA247) Suppresses Anti-CD3 Activated Human T-Cell Proliferation and Effectively Treats Experimental Autoimmune Uveitis in Rats (2008) (0)
The Role of Double Negative T Cells in Uveitis (2010) (0)
CHAPTER 49 – Ocular Disease (2006) (0)
Gallium scintigraphy in the investigation of retinal inflammatory vasculopathy (2010) (0)
Ocular Complications in Vogt-Koyanagi-Harada Disease (2007) (0)
Effects Of Interleukin 1 Receptor Antagonist On Experimental Autoimmune Uveoretinitis In Mice (2004) (0)
Infections Associated with Retinal Autoimmunity (2004) (0)
Multifocal Electroretinograms in Serpiginous Choroiditis and the Variability in Correlation to Visible Macular Lesions (2005) (0)
Interactions between retinal glial cells and immune mononuclear cells. (1986) (0)
Abrogation of potent humoral vaccine responses in patients on long-term anti-CD25 therapy (B196) (2007) (0)
Autoimmune and autoinflammatory mechanisms in uveitis (2014) (0)
International workshop on intermediate uveitis, Gütersloh, July 5-6, 1990. (1991) (0)
Treatment of Endogenous Uveitis (1988) (0)
Complement Component C5a Induced Expression of Il-22 and Il-17 is Associated With Age-Related Macular Degeneration Pathogenesis (2010) (0)
Immune Therapy for Autoimmune Uveitis (1992) (0)
Autofluorescence Measurements Can be Used to Differentiate Normal, Activated or Malignant Lymphocyte Populations (2007) (0)
Clinical andimmunopathological studies ofpars planitis inafamily (1988) (0)
Expression kinetics of glucocorticoid receptor isoforms predicts treatment response to glucocorticoids in uveitis patients (2015) (0)
The Expression Of Pd-l1 And Pd-l2 On Human Retinal Pigment Epithelial Cells Are Differentially Regulated By Cytokines (2011) (0)
CD14(++)CD16(+) monocytes are enriched in inflammatory diseases and promote the sensitivity of T-cells to corticosteroids (2014) (0)
Increased Blood CD1c(high) Myeloid Dendritic Cells with Low Antigen Uptake Enhance CD4 Helper T cell Responses in Noninfectious Uveitis (2014) (0)
Validation study for an image-based standardized grading system for scleritis (2016) (0)
Visual Acuity in Patients with Non-Infectious Uveitis: Outcome Over Time and Risk Factors (2012) (0)
Association of Propionibacterium acnes endophthalmitis with HLA-DQw5. (1996) (0)
The Effect of Subsets of Monocytes on T cell activation and its implication in uveitis (2013) (0)
Primary intraocular lymphoma (PIOL) is a variant of primary central nervous system lymphoma in which lymphoma cells are initially present only in the eyes without evidence of disease in the brain or cerebrospinal fluid. Patients with PIOL (2001) (0)
Whole transcriptome profiling of peripheral CD4+ T-cells in age-related macular degeneration patients using RNA-seq (2015) (0)
Autofluorescence Changes in Uveitic Macular Edema (2010) (0)
18 – Postsurgical Uveitis (2010) (0)
Su.58. Inflammatory Response and Involvement of Immune Components in a Laser Induced CNV (Choroid neovascularization) Mouse Model (2008) (0)
CFH and HTRA1 risk alleles in Caucasian and African American ocular sarcoidosis patients (2012) (0)
Serum Th17 Cytokines in Uveitis Patients (2012) (0)
Increased expression of p21 in CD14+ human monocytes correlates with telomere shortening in ocular sarcoidosis patients (2014) (0)
Le lymphome oculocérébral primitif: diagnostic clinique et cytopathologique (1999) (0)
Clinical Outcomes of Ocular Inflammatory Disease Patients Treated With Cyclosporine-A as a Single Immunomodulatory Agent (2009) (0)
Expression of Gitr Ligand (gitrl) in Retinal Pigment Epithelial Cells Differentially Modulates Inflammatory Cytokines and Chemokines and Abrogates Immunosuppressive Function of Ocular Tissue (2006) (0)
Patients With Scleritis Are Deficient in Their Ability to Regulate Activities of Pro–inflammatory Cytokines (2005) (0)
Manufacture of a medicament for the treatment of ocular inflammation by blocking zelladhäsionsmolekulen (1992) (0)
Intermediate (CD14++CD16+) monocytes are expanded in non-infectious uveitis patients and have a reduced capacity to drive Th17 differentiation. (2015) (0)
CD4+ and CD8+ T Lymphocyte Levels in Uveitis Patients Treated with Cellcept (2016) (0)
Induction of Oral Tolerance IL-4 and IL-10 Are Both Required for the (2017) (0)
Immunopathogenic mechanisms of experimental autoimmune uveoretinitis in rats. (1986) (0)
Surface Expression of Glucocorticoid Induced TNF Receptor Family Related (GITR) Serves as a Marker for Non-Infectious Uveitis (2003) (0)
Effect of HDACi Givinostat in Treating Experimental Ocular Autoimmunity (2015) (0)
The Effects of the Cyclosporines on Ocular Inflammatory Disease (1987) (0)
Foveal Hypoautofluorescence: Does It Correlate to Visual Acuity in White Dot Syndromes?—Reply (2010) (0)
Multifocal Choroiditis and Panuveitis (2016) (0)
HLA polymorphisms and autoimmune markers in non-paraneoplastic autoimmune retinopathy (AIR) (2013) (0)
Chapter 12 – Rules to Prevent Conflict of Interest for Clinical Investigators Conducting Human Subjects Research (2012) (0)
Ocular Disease in Patients With Wegener’s Granulomatosis (2008) (0)
GITR Promotes Activation Induced Apoptosis of Human NK Cells (2007) (0)
Choroidal Neovascularization in the Setting of Uveitis: Clinical Features and Visual Outcomes (2009) (0)
Discovering cell types in flow cytometry data with random matrix theory (2016) (0)
Autoaggressive T Cells Mouse Model of Uveitis and Identify Antigens Are Pathogenic in the Humanized Uveitis-Associated Epitopes of Retinal (2011) (0)
Diagnostic and therapeutic challenges. (2010) (0)
Functional Mechanisms Of Concanavalin A (cona) Induced Regulatory T Cell Suppression In Humans (2011) (0)
An Evaluation of the Diagnostic Work-Up for Primary Intraocular Lymphoma (2009) (0)
Variability in full-field electoretinogram measurements in patients with birdshot chorioretinopathy (2016) (0)
Gene Expression and Epigenomic Profiling of Th17 Cells in Steroid Refractory Uveitis (2010) (0)
Synthetic Tellurium Compound, AS101, Down-regulates Proinflammatory Molecules In Retinal Pigment Epithelium (2011) (0)
Workshop on Vogt-Koyanagi-harada's disease (1988) (0)
Cryopexy enhances the development of experimental autoimmune uveoretinitis (EAU) (1987) (0)
The Effect of HDACi Givinostat on the Expression of Immune Markers Related to Human Ocular Inflammation (2015) (0)
Indocyanine Green Angiography (ICGA) for the Detection of Disease Progression or Recurrence in Uveitis (2014) (0)
CD56+ CD3+CD8bright Natural Killer T–Cells Appear to Correlate With Inflammatory Activity in Behçet’s Disease (2006) (0)
Rituximab for Autoimmune Retinopathy (2016) (0)
Peripheral Monocyte Subset-Derived Macrophages Show Distinct Expression Kinetics of Immune Biomarkers Associated with Ocular Autoimmunity (2015) (0)
Editorial Inflammation in Retinal Disease (2013) (0)
Comparative Study on DNA Methylation of IL-10 Gene Promoter in Human Immune Cells (2009) (0)
Uveitis, 4th Edition. Fundamentals and Clinical Practice: Expert Consult - Online and Print (2010) (0)
Primary Intraocular Lymphoma: How Many Diagnostic Procedures Are Needed For A Definitive Diagnosis? (2011) (0)
Spectral Domain OCT And Autofluorescence In Active Posterior Uveitis (2012) (0)
Ultrastructural changes of retinal vascular endothelial cells at the onset of uveitis (1993) (0)
Azathioprine for Non-infectious Ocular Inflammation (2009) (0)
Chapter 26 IMMUNE THERAPY FOR AUTOIMMUNE UVEITIS (1992) (0)
Subconjunctival Sirolimus in the Treatment of Autoimmune Non-Necrotizing Anterior Scleritis: Results of a Pilot Clinical Trial (2014) (0)
Punctate Inner Choroidopathy (2016) (0)
Expression of MSR-1—a Class-A Macrophage Scavenger Receptor—May Be Altered in Ocular Sarcoidosis (2015) (0)
31 – Other Ocular Disorders and the Immune Response: Who Would Have Thought? (2010) (0)
Cyclosporin A (1987) (0)
Long-term visual acuity outcomes following cataract surgery in eyes with ocular inflammatory disease (2023) (0)
Intraocular inflammatory disease. (1990) (0)
Utility of a Gamma Interferon assay as an alternative to PPD TB skin testing in selected patients with intraocular inflammatory disease. (2004) (0)
Characteristics Of PPD Positive Patients In A Tertiary Referral Center’S Uveitis Population (2012) (0)
Treatment of autoimmune uveoretinitis in humans (1990) (0)
The adjuvant Labrafil M2125 CS Enhances The Therapeutic induction of Oral Tolerance in the Experimental Autoimmune Uveitis (2011) (0)
Epigenetic Regulations in Age-related Macular Degeneration (2011) (0)
Monitoring Autoimmune Reactivity within the Retina (2016) (0)
CD14(++)CD16(-) monocytes polarise memory T cells to a Th17 phenotype which is refractory to glucocorticoid treatment (2013) (0)
Differentiating Endophthalmitis from Uveitis and Vitreoretinal Lymphoma by Aqueous and Vitreous IL-6 and IL-10 (2016) (0)
Early Color Vision and Erg Alterations in Posterior Uveitis (1989) (0)
Molecular Analysis of IgH Gene Rearrangements in 61 Patients With Primary Intraocular Lymphoma (2007) (0)
Pediatric Uveitis: Changes in Treatment Trends and Outcomes in 1980s and 1990s (2009) (0)

This paper list is powered by the following services:

Robert Burton Nussenblatt's Academic­Influence.com Rankings

Robert Burton Nussenblatt's Degrees

Why Is Robert Burton Nussenblatt Influential?

Robert Burton Nussenblatt's Published Works

Published Works

Robert Burton Nussenblatt's AcademicInfluence.com Rankings